<link rel="stylesheet" href="/res/styles.39be4579664c3a48.css">
Artículo

Identification of Prominin2 as a new player of cardiomyocyte senescence in the aging heart

Maggiorani, D. ; Santin, Y. ; Formoso, Karina Icon; Drapé, E. ; Martini, H. ; Brun, S. ; Cousin, G. ; Lairez, O. ; Lezoualc'h, F. ; Parini, A. ; Douin Echinard, V. ; Mialet Perez, J.

Otros responsables

Fecha

05/2024

Editorial

Wiley Blackwell Publishing, Inc

Revista

Aging Cell

Título del libro

Nombre del evento

Fecha del evento

Institución organizadora

ISSN

1474-9718

eISSN

ISBN

Idioma

Inglés

Tipo del evento

Clasificación temática

Resumen

The aging heart is characterized by a number of structural changes leading to ventricular stiffness, impaired resistance to stress and increased risk of developing heart failure (HF). Genetic or pharmacological removal of senescent cells has recently demonstrated the possibility to relieve some cardiac aging features such as hypertrophy and fibrosis. However, the contribution of the different cell types in cardiac aging remains fragmentary due to a lack of cell-specificmarkers. Cardiomyocytes undergo post-mitotic senescence in response to telomere damage, characterized by persistent DNA damage response and expression of the classical senescence markers p21 and p16, which are shared by many other cell types. In the present study, we usedtranscriptomic approaches to discover new markers specific for cardiomyocyte senescence.We identified Prominin2 (Prom2), encoding a transmembrane glycoprotein, as the most upregulated gene in cardiomyocytes of aged mice compared to young mice. We showed that Prom2 was upregulated by a p53-dependent pathway in stress-induced premature senescence. Prom2 expression correlated with cardiomyocyte hypertrophy in the hearts of aged mice and was increased in atrial samples of patients with HF with preserved ejection fraction. Consistently, Prom2 overexpression was sufficient to drive senescence, hypertrophy and resistance to cytotoxic stress while Prom2 shRNA silencing inhibited these features in doxorubicin-treatedcardiac cells.In conclusion, we identified Prom2 as a new player of cardiac aging, linking cardiomyocyte hypertrophy to senescence. These results could provide a better understanding and targeting of cell-type specific senescence in age-associated cardiac diseases.

Aprobación

Revisión

Complementado por

Referenciado por

Licencia Creative Commons

Excepto donde se indique lo contrario, la licencia de este ítem se describe como by